Mayne Pharma Group Ltd.

Mayne Pharma Group Ltd.

Mayne Pharma Group Ltd.

Overview
Date Founded

2005

Headquarters

1528 Main North Road,Salisbury South,Salisbury, South Australia (SA) 5106

Type of Company

Public

Employees (Worldwide)

1,000

Industries

Pharmaceuticals

Company Description

Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment involves in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty brands segments includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment offers manufacturing and selling of branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.

Contact Data
Trying to get in touch with decision makers at Mayne Pharma Group Ltd.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer, MD & Executive Director

Chief Financial Officer

President-International Operations

President, Generics Products Division

Director-Product Development

Executive Vice President, Specialty Brands

Vice President, Quality

Executive Vice President & General Counsel

Secretary & Associate General Counsel

Vice President-Group Human Resources

Board of Directors

Member of the Dean's Advisory Group at The University of Sydney

Director at Sutter Health

Director at Australian Leisure & Hospitality Group Ltd.

Chief Executive Officer, MD & Executive Director at Mayne Pharma Group Ltd.

Partner at PricewaterhouseCoopers LLP

Former Dean at University of Sydney - Sydney Medical School

Former Chief Executive Officer at Juniper Pharmaceuticals, Inc.

Paths to Mayne Pharma Group Ltd.
Potential Connections via
Relationship Science
You
Mayne Pharma Group Ltd.
Owners & Shareholders
Details Hidden

IML has a conservative investment style with a long-term focus and aims to deliver consistent returns for clients. The firm employs a fundamental, quality & value-based approach to investing. They utilize active, bottom-up approach to identifying, researching and valuing companies. Their approach is systematic, disciplined and focuses on finding companies that meet their investment quality criteria and then determining an appropriate valuation for those companies.

Details Hidden

IML has a conservative investment style with a long-term focus and aims to deliver consistent returns for clients. The firm employs a fundamental, quality & value-based approach to investing. They utilize active, bottom-up approach to identifying, researching and valuing companies. Their approach is systematic, disciplined and focuses on finding companies that meet their investment quality criteria and then determining an appropriate valuation for those companies.

Recent Transactions
Details Hidden

Mayne Pharma Group Ltd. purchases Spear Pharmaceuticals, Inc. /Generic Efudex Operations from Bausch Health Cos., Inc.

Details Hidden

Mayne Pharma Group Ltd. purchases Teva Pharmaceutical Industries Ltd. /Generic Products Portf from Teva Pharmaceutical Industries Ltd.

Details Hidden

Mayne Pharma Group Ltd. purchases Forest Laboratories LLC /Esgic Esgic Plus Lorcet Lorcet Plus from Allergan Plc

Transaction Advisors
Legal Advisor

Advised onMayne Pharma Group Ltd. purchases Mayne Pharma, Inc.

Legal Advisor

Advised onMayne Pharma Group Ltd. purchases Mayne Pharma, Inc.

Legal Advisor

Advised onMayne Pharma Group Ltd. purchases Mayne Pharma, Inc.

Legal Advisor

Advised onMayne Pharma Group Ltd. purchases Mayne Pharma, Inc.

Legal Advisor

Advised onMayne Pharma Group Ltd. purchases Mayne Pharma, Inc.

Advisors & Consultants
Advisor

Chief Financial Officer at NIB Holdings Ltd.

Legal Advisor

Partner at Herbert Smith Freehills LLP

Clients

X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan and is headquartered in Cambridge, MA.

Boryung Pharmaceutical Co., Ltd. engages in the manufacture of of drug products. Its main products include Kanarb, Dukarb, Tuvero, TODULA, BESTO, and gelfosM. Its products include cardiovascular, antibiotics, anticancer, amino acid, cosmetics, gastrointestinal, and API. The company was founded on November 11, 1963 and is headquartered in Seoul, South Korea.

Exea Corp. is a private company headquartered in Spain that operates in several countries. The firm operates as a holding company with interests in manufactures and distributes perfumery, cosmetics and personal care products.

Key Stats and Financials As of 2020
Market Capitalization
$434M
Total Enterprise Value
$588M
Earnings Per Share
$-0.04
Enterprise Value / Sales
1.87x
TEVNet Income
-9.2x
Debt TEV
0.47x
EBITDAMargin
15.85%
Enterprise Value EBITDAOperating
11.78x
Three Year Compounded Annual Growth Rate Of Revenue
-7.24%
Revenue
$315M
Total Debt
$274M
Total Equity
$718M
Net Profit
$-63.9M
EBITDA
$49.9M
Suppliers
Corium International, Inc. Holding Companies | Menlo Park, California

Corium International, Inc. is a pharmaceutical company. It offers products such as corplex donepezil and memantine. The company was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA.

Mithra Pharmaceuticals SA Wholesale: Consumer Non-Durables/Sundries | Liege, Bel

Mithra Pharmaceuticals SA is a belgian biotech company, which engages in the development, manufacture, and commercialization of proprietary and differentiated drugs and generic products dedicated to female healthcare. Mithra also develops and manufactures complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers. The company was founded by Jean-Michel Foidart and Fran├žois Fornieri on July 8, 1999 and is headquartered in Liege, Belgium.

Douglas Pharmaceuticals Ltd. Pharmaceuticals | Auckland, New Zealand

Douglas Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products include acitretin capsules, anastrozole tablets, Azathioprine film-coated tablets, Clozapine tablets, Dutasteride, Quetiapinetablets and Rivastigmine capsules. The company was founded by Graeme Bruce Douglas in 1967 and is headquartered in Auckland, New Zealand.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Mayne Pharma Group Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Mayne Pharma Group Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Mayne Pharma Group Ltd..